153 related articles for article (PubMed ID: 30203597)
1. Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz-Jampel Syndrome.
Martinez JR; Grindel BJ; Hubka KM; Dodge GR; Farach-Carson MC
J Cell Biochem; 2019 Feb; 120(2):2138-2150. PubMed ID: 30203597
[TBL] [Abstract][Full Text] [Related]
2. Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.
Sadatsuki R; Kaneko H; Kinoshita M; Futami I; Nonaka R; Culley KL; Otero M; Hada S; Goldring MB; Yamada Y; Kaneko K; Arikawa-Hirasawa E; Ishijima M
J Orthop Res; 2017 Apr; 35(4):837-846. PubMed ID: 27238423
[TBL] [Abstract][Full Text] [Related]
3. Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration.
Hayes AJ; Farrugia BL; Biose IJ; Bix GJ; Melrose J
Front Cell Dev Biol; 2022; 10():856261. PubMed ID: 35433700
[TBL] [Abstract][Full Text] [Related]
4. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
5. A missense mutation in domain III in HSPG2 in Schwartz-Jampel syndrome compromises secretion of perlecan into the extracellular space.
Iwata S; Ito M; Nakata T; Noguchi Y; Okuno T; Ohkawara B; Masuda A; Goto T; Adachi M; Osaka H; Nonaka R; Arikawa-Hirasawa E; Ohno K
Neuromuscul Disord; 2015 Aug; 25(8):667-71. PubMed ID: 26031903
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
[TBL] [Abstract][Full Text] [Related]
7. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.
Arikawa-Hirasawa E; Le AH; Nishino I; Nonaka I; Ho NC; Francomano CA; Govindraj P; Hassell JR; Devaney JM; Spranger J; Stevenson RE; Iannaccone S; Dalakas MC; Yamada Y
Am J Hum Genet; 2002 May; 70(5):1368-75. PubMed ID: 11941538
[TBL] [Abstract][Full Text] [Related]
9. Perlecan Knockdown Significantly Alters Extracellular Matrix Composition and Organization During Cartilage Development.
Ocken AR; Ku MM; Kinzer-Ursem TL; Calve S
Mol Cell Proteomics; 2020 Jul; 19(7):1220-1235. PubMed ID: 32381549
[TBL] [Abstract][Full Text] [Related]
10. Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
[TBL] [Abstract][Full Text] [Related]
11. Modular Proteoglycan Perlecan/
Martinez JR; Dhawan A; Farach-Carson MC
Genes (Basel); 2018 Nov; 9(11):. PubMed ID: 30453502
[TBL] [Abstract][Full Text] [Related]
12. Impact of the heparan sulfate proteoglycan perlecan on human disease and health.
Arikawa-Hirasawa E
Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1117-C1122. PubMed ID: 35417267
[TBL] [Abstract][Full Text] [Related]
13. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Grindel BJ; Martinez JR; Tellman TV; Harrington DA; Zafar H; Nakhleh L; Chung LW; Farach-Carson MC
Sci Rep; 2018 May; 8(1):7262. PubMed ID: 29740048
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of hspg2 is associated with abnormal mandibular joint formation and neural crest cell dysfunction in zebrafish.
Castellanos BS; Reyes-Nava NG; Quintana AM
BMC Dev Biol; 2021 Mar; 21(1):7. PubMed ID: 33678174
[TBL] [Abstract][Full Text] [Related]
15. Statin-Induced Myopathy in a Patient with Schwartz-Jampel Syndrome.
Rajpal MK; Sedki FK; Eid TJ
J Pharm Pract; 2023 Nov; ():8971900231213694. PubMed ID: 37931642
[TBL] [Abstract][Full Text] [Related]
16. Synovial perlecan is required for osteophyte formation in knee osteoarthritis.
Kaneko H; Ishijima M; Futami I; Tomikawa-Ichikawa N; Kosaki K; Sadatsuki R; Yamada Y; Kurosawa H; Kaneko K; Arikawa-Hirasawa E
Matrix Biol; 2013 Apr; 32(3-4):178-87. PubMed ID: 23339896
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Human-Induced Pluripotent Stem Cells Derived from a Patient with Schwartz-Jampel Syndrome Revealed Distinct Hyperexcitability in the Skeletal Muscles.
Yamashita Y; Nakada S; Nakamura K; Sakurai H; Ohno K; Goto T; Mabuchi Y; Akazawa C; Hattori N; Arikawa-Hirasawa E
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979792
[TBL] [Abstract][Full Text] [Related]
18. Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome.
Rodgers KD; Sasaki T; Aszodi A; Jacenko O
Hum Mol Genet; 2007 Mar; 16(5):515-28. PubMed ID: 17213231
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel splice site HSPG2 mutation and prenatal diagnosis in Schwartz Jampel Syndrome type 1 using whole exome sequencing.
Das Bhowmik A; Dalal A; Matta D; Kandadai RM; Kanikannan MA; Aggarwal S
Neuromuscul Disord; 2016 Nov; 26(11):809-814. PubMed ID: 27521129
[TBL] [Abstract][Full Text] [Related]
20. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.
Thompson WR; Modla S; Grindel BJ; Czymmek KJ; Kirn-Safran CB; Wang L; Duncan RL; Farach-Carson MC
J Bone Miner Res; 2011 Mar; 26(3):618-29. PubMed ID: 20814969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
